Both in Testing Laboratories
UL Solutions vs 20/20 Biolabs
Over the past year ULS returned −5.9% and AIDX returned −99.0%; their daily moves had a correlation of 0.70.
ULS −5.9% AIDX −99.0%Growth of $1, one year, split-adjusted
| Metric | ULS | AIDX |
|---|---|---|
| Price | $77.79 | $0.2472 |
| Market cap | $15.70B | $3.2M |
| Today | −3.25% | +5.21% |
| 1 month | +13.8% | −29.9% |
| 6 months | −25.8% | — |
| Year to date | −1.4% | — |
| 1 year | −1.0% | — |
| Revenue growth (YoY) | +5.2% | — |
| Gross margin | 51.1% | 41.7% |
| Net margin | 30.1% | −376.8% |
| P/E (TTM) | 31.1× | — |
| Price / sales | 5.0× | — |
| Net cash | $133.0M | $4.5M |
| Dividend yield | 0.75% | — |
| Volatility (60d) | 32.1% | — |
| Short % of float | 7.2% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).